Stereotaxis Total Long Term Liabilities 2010-2025 | STXS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Stereotaxis total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.6B
Intuitive Surgical (ISRG)	$177.8B
Edwards Lifesciences (EW)	$46.9B
IDEXX Laboratories (IDXX)	$45.5B
Alcon (ALC)	$45.3B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$33.9B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.7B
Waters (WAT)	$18B
SONOVA HOLDING (SONVY)	$17.5B
Hologic (HOLX)	$14.8B
Sysmex ADR (SSMXY)	$10.7B
Penumbra (PEN)	$9B
Masimo (MASI)	$8.9B
Globus Medical (GMED)	$7.4B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.2B
Integer Holdings (ITGR)	$3.8B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.1B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Veracyte (VCYT)	$2B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Tandem Diabetes Care (TNDM)	$1.1B